http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 26 Aug 2026 16:41:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Stonepine+Capital+Management%2C+LLC/26982384.html si-local-file:///var/storage/secattach/20260826/26982384.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Stonepine+Capital+Management%2C+LLC/26982384.html Wed, 26 Aug 2026 16:41:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Stonepine+Capital+Management%2C+LLC/26982384.html si-local-file:///var/storage/secattach/20260826/26982384.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Stonepine+Capital+Management%2C+LLC/26982384.html Wed, 26 Aug 2026 16:41:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Nijhawan+Pardeep/26975899.html si-local-file:///var/storage/secattach/20260825/26975899.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Nijhawan+Pardeep/26975899.html Tue, 25 Aug 2026 18:00:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Nijhawan+Pardeep/26975899.html si-local-file:///var/storage/secattach/20260825/26975899.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Nijhawan+Pardeep/26975899.html Tue, 25 Aug 2026 18:00:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Velan+Capital+Investment+Management+LP/26975270.html si-local-file:///var/storage/secattach/20260825/26975270.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Velan+Capital+Investment+Management+LP/26975270.html Tue, 25 Aug 2026 16:39:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Velan+Capital+Investment+Management+LP/26975270.html si-local-file:///var/storage/secattach/20260825/26975270.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Edesa+Biotech%2C+Inc.++++++++++++++++++++Filed+by%3A+Velan+Capital+Investment+Management+LP/26975270.html Tue, 25 Aug 2026 16:39:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Edesa+Biotech%2C+Inc.+++++++For%3A+Aug+19/26956384.html si-local-file:///var/storage/secattach/20260820/26956384.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Edesa+Biotech%2C+Inc.+++++++For%3A+Aug+19/26956384.html Thu, 20 Aug 2026 16:15:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Edesa+Biotech%2C+Inc.+++++++For%3A+Aug+19/26956384.html si-local-file:///var/storage/secattach/20260820/26956384.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Edesa+Biotech%2C+Inc.+++++++For%3A+Aug+19/26956384.html Thu, 20 Aug 2026 16:15:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Edesa+Biotech%2C+Inc.++++++++++++++++++/26956270.html si-local-file:///var/storage/secattach/20260820/26956270.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Edesa+Biotech%2C+Inc.++++++++++++++++++/26956270.html Thu, 20 Aug 2026 16:10:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Edesa+Biotech%2C+Inc.++++++++++++++++++/26956270.html si-local-file:///var/storage/secattach/20260820/26956270.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Edesa+Biotech%2C+Inc.++++++++++++++++++/26956270.html Thu, 20 Aug 2026 16:10:00 -0400 EDSA O.15990112 http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+prices+%2425M+public+offering+on+Nasdaq/26951731.html <p>Edesa Biotech, Inc. (Nasdaq: EDSA) announced the pricing of an underwritten public offering expected to generate approximately $25.0 million in gross proceeds, before underwriting discounts, commissions, and other estimated expenses.</p> <p>The Toronto-based clinical-stage biopharmaceutical company said the offering consists of 3,870,500 common shares with accompanying warrants to purchase an equal number of common shares, along with pre-funded warrants to purchase up to 675,000 common shares with accompanying warrants. The combined public offering price per common share and accompanying warrant is $5.50. The accompanying common share warrants carry an exercise price of $7.50 per share.</p> <p>The warrants are immediately exercisable upon issuance and http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+prices+%2425M+public+offering+on+Nasdaq/26951731.html Wed, 19 Aug 2026 22:20:15 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+prices+%2425M+public+offering+on+Nasdaq/26951731.html <p>Edesa Biotech, Inc. (Nasdaq: EDSA) announced the pricing of an underwritten public offering expected to generate approximately $25.0 million in gross proceeds, before underwriting discounts, commissions, and other estimated expenses.</p> <p>The Toronto-based clinical-stage biopharmaceutical company said the offering consists of 3,870,500 common shares with accompanying warrants to purchase an equal number of common shares, along with pre-funded warrants to purchase up to 675,000 common shares with accompanying warrants. The combined public offering price per common share and accompanying warrant is $5.50. The accompanying common share warrants carry an exercise price of $7.50 per share.</p> <p>The warrants are immediately exercisable upon issuance and http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+prices+%2425M+public+offering+on+Nasdaq/26951731.html Wed, 19 Aug 2026 22:20:15 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+prices+%2425M+public+offering+on+Nasdaq/26951731.html <p>Edesa Biotech, Inc. (Nasdaq: EDSA) announced the pricing of an underwritten public offering expected to generate approximately $25.0 million in gross proceeds, before underwriting discounts, commissions, and other estimated expenses.</p> <p>The Toronto-based clinical-stage biopharmaceutical company said the offering consists of 3,870,500 common shares with accompanying warrants to purchase an equal number of common shares, along with pre-funded warrants to purchase up to 675,000 common shares with accompanying warrants. The combined public offering price per common share and accompanying warrant is $5.50. The accompanying common share warrants carry an exercise price of $7.50 per share.</p> <p>The warrants are immediately exercisable upon issuance and http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+prices+%2425M+public+offering+on+Nasdaq/26951731.html Wed, 19 Aug 2026 22:20:15 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+prices+%2425M+public+offering+on+Nasdaq/26951731.html <p>Edesa Biotech, Inc. (Nasdaq: EDSA) announced the pricing of an underwritten public offering expected to generate approximately $25.0 million in gross proceeds, before underwriting discounts, commissions, and other estimated expenses.</p> <p>The Toronto-based clinical-stage biopharmaceutical company said the offering consists of 3,870,500 common shares with accompanying warrants to purchase an equal number of common shares, along with pre-funded warrants to purchase up to 675,000 common shares with accompanying warrants. The combined public offering price per common share and accompanying warrant is $5.50. The accompanying common share warrants carry an exercise price of $7.50 per share.</p> <p>The warrants are immediately exercisable upon issuance and http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+prices+%2425M+public+offering+on+Nasdaq/26951731.html Wed, 19 Aug 2026 22:20:15 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Press+Releases/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html <p align="justify">TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggregate of 3,870,500 common shares and (ii) in lieu of common shares to investors who so choose, pre-funded warrants to purchase up to 675,000 common shares and accompanying common share warrants to purchase an aggregate of 675,000 common shares, at an exercise price of $0.0001 http://www.streetinsider.com/Press+Releases/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html Wed, 19 Aug 2026 22:20:00 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Press+Releases/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html <p align="justify">TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggregate of 3,870,500 common shares and (ii) in lieu of common shares to investors who so choose, pre-funded warrants to purchase up to 675,000 common shares and accompanying common share warrants to purchase an aggregate of 675,000 common shares, at an exercise price of $0.0001 http://www.streetinsider.com/Press+Releases/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html Wed, 19 Aug 2026 22:20:00 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Press+Releases/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html <p align="justify">TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggregate of 3,870,500 common shares and (ii) in lieu of common shares to investors who so choose, pre-funded warrants to purchase up to 675,000 common shares and accompanying common share warrants to purchase an aggregate of 675,000 common shares, at an exercise price of $0.0001 http://www.streetinsider.com/Press+Releases/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html Wed, 19 Aug 2026 22:20:00 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Press+Releases/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html <p align="justify">TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggregate of 3,870,500 common shares and (ii) in lieu of common shares to investors who so choose, pre-funded warrants to purchase up to 675,000 common shares and accompanying common share warrants to purchase an aggregate of 675,000 common shares, at an exercise price of $0.0001 http://www.streetinsider.com/Press+Releases/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html Wed, 19 Aug 2026 22:20:00 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Globe+Newswire/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html <p align="justify">TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggregate of 3,870,500 common shares and (ii) in lieu of common shares to investors who so choose, pre-funded warrants to purchase up to 675,000 common shares and accompanying common share warrants to purchase an aggregate of 675,000 common shares, at an exercise price of $0.0001 http://www.streetinsider.com/Globe+Newswire/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html Wed, 19 Aug 2026 22:20:00 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Globe+Newswire/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html <p align="justify">TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggregate of 3,870,500 common shares and (ii) in lieu of common shares to investors who so choose, pre-funded warrants to purchase up to 675,000 common shares and accompanying common share warrants to purchase an aggregate of 675,000 common shares, at an exercise price of $0.0001 http://www.streetinsider.com/Globe+Newswire/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html Wed, 19 Aug 2026 22:20:00 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Globe+Newswire/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html <p align="justify">TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggregate of 3,870,500 common shares and (ii) in lieu of common shares to investors who so choose, pre-funded warrants to purchase up to 675,000 common shares and accompanying common share warrants to purchase an aggregate of 675,000 common shares, at an exercise price of $0.0001 http://www.streetinsider.com/Globe+Newswire/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html Wed, 19 Aug 2026 22:20:00 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/Globe+Newswire/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html <p align="justify">TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggregate of 3,870,500 common shares and (ii) in lieu of common shares to investors who so choose, pre-funded warrants to purchase up to 675,000 common shares and accompanying common share warrants to purchase an aggregate of 675,000 common shares, at an exercise price of $0.0001 http://www.streetinsider.com/Globe+Newswire/Edesa+Biotech+Announces+Pricing+of+%2425.0+Million+Public+Offering/26951730.html Wed, 19 Aug 2026 22:20:00 -0400 A.14185667 EDSA O.15990112 O.22066148 http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Edesa+Biotech%2C+Inc.++++++++++++++++++/26950061.html si-local-file:///var/storage/secattach/20260819/26950061.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Edesa+Biotech%2C+Inc.++++++++++++++++++/26950061.html Wed, 19 Aug 2026 16:06:00 -0400 EDSA O.15990112 http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Edesa+Biotech%2C+Inc.++++++++++++++++++/26950061.html si-local-file:///var/storage/secattach/20260819/26950061.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Edesa+Biotech%2C+Inc.++++++++++++++++++/26950061.html Wed, 19 Aug 2026 16:06:00 -0400 EDSA O.15990112 http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+launches+public+offering+of+common+shares/26949925.html <p>Edesa Biotech, Inc. (Nasdaq: EDSA) announced the commencement of an underwritten public offering of common shares, or pre-funded warrants in lieu thereof, along with accompanying common share warrants, according to a company statement.</p> <p>The Toronto-based clinical-stage biopharmaceutical company said it expects to grant underwriters a 30-day option to purchase additional common shares and warrants totaling up to 15% of the shares offered under the same terms and conditions.</p> <p>Guggenheim Securities is serving as the sole book-running manager for the offering.</p> <p>Edesa said it intends to use net proceeds for general corporate purposes, which may include working capital, capital expenditures, and research and development http://www.streetinsider.com/Equity+Offerings/Edesa+Biotech+launches+public+offering+of+common+shares/26949925.html Wed, 19 Aug 2026 16:01:10 -0400 A.14185667 EDSA O.15990112 O.22066148